Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
EARGO INC (EAR) Stock Price & Overview
NASDAQ:EAR • US2700872086
Current stock price
2.57 USD
-0.11 (-4.1%)
At close:
2.6 USD
+0.03 (+1.17%)
After Hours:
The current stock price of EAR is 2.57 USD. Today EAR is down by -4.1%. In the past month the price decreased by -2.65%. In the past year, price decreased by -66.14%.
EAR Key Statistics
52-Week Range1.465 - 7.52
Current EAR stock price positioned within its 52-week range.
1-Month Range2.56 - 2.87
Current EAR stock price positioned within its 1-month range.
- Market Cap
- 53.379M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -57.98
- Dividend Yield
- N/A
EAR Stock Performance
Today
-4.1%
1 Week
-2.28%
1 Month
-2.65%
3 Months
N/A
Longer-term
6 Months -15.18%
1 Year -66.14%
2 Years -97.33%
3 Years -99.78%
5 Years N/A
10 Years N/A
EAR Stock Chart
EAR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to EAR. When comparing the yearly performance of all stocks, EAR is a bad performer in the overall market: 90.64% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
EAR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to EAR. The financial health of EAR is average, but there are quite some concerns on its profitability.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
EAR Earnings
Next Earnings DateMay 9, 2024
Last Earnings DateFeb 22, 2024
PeriodQ3 / 2023
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -3.73%
EAR Forecast & Estimates
8 analysts have analysed EAR and the average price target is 2.04 USD. This implies a price decrease of -20.62% is expected in the next year compared to the current price of 2.57.
For the next year, analysts expect an EPS growth of 93.38% and a revenue growth 19.87% for EAR
Analysts
Analysts45
Price Target2.04 (-20.62%)
EPS Next Y93.38%
Revenue Next Year19.87%
EAR Financial Highlights
Over the last trailing twelve months EAR reported a non-GAAP Earnings per Share(EPS) of -57.98. The EPS increased by 90.73% compared to the year before.
Income Statements
Revenue(TTM)41.11M
Net Income(TTM)-108.17M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -154.97% | ||
| ROE | -239.84% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%96.77%
Sales Q2Q%4.55%
EPS 1Y (TTM)90.73%
Revenue 1Y (TTM)19.51%
EAR Ownership
Ownership
Inst OwnersN/A
Shares20.77M
Float3.82M
Ins Owners40.87%
Short Float %N/A
Short RatioN/A
EAR Industry Overview
EAR operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
61/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
17%
Outperformed 17% of sub-industries
3 Month Rank
12%
Outperformed 12% of sub-industries
6 Month Rank
10%
Outperformed 10% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 3.2%
- New Lows
- 13.4%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.3
- Average Fwd P/E
- 27.5
- Average Debt/Equity
- 0.5
EAR Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.44 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.32 | 157.763B | ||
| SYK | STRYKER CORP | 17.8 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.57 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.94 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.47 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.45 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.66 | 27.761B | ||
| DXCM | DEXCOM INC | 20.08 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.12 | 15.956B | ||
| PEN | PENUMBRA INC | 64.05 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 19.74 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About EAR
Company Profile
Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. The company is headquartered in San Jose, California and currently employs 243 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. The company is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The firm markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.
Company Info
IPO: 2020-10-16
EARGO INC
2665 North First Street, Suite 300
San Jose CALIFORNIA 95110 US
CEO: Christian Gormsen
Employees: 243
Phone: 16503517700
EARGO INC / EAR FAQ
What does EARGO INC do?
Eargo, Inc. is engaged in the development of hearing aids and headsets solutions. The company is headquartered in San Jose, California and currently employs 243 full-time employees. The company went IPO on 2020-10-16. The firm is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. The company is marketing various versions of hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, Eargo 6 and Eargo 7. The firm markets and sells its hearing aids primarily in a direct-to-consumer format, engaging consumers through a mix of digital and traditional marketing as well as select commercial partnership, and omni-channel (including retail). Its devices are self-fitting hearing aids and are adjusted by the user to meet the user’s hearing needs, without pre-programming or a hearing test from a hearing care professional.
What is the current price of EAR stock?
The current stock price of EAR is 2.57 USD. The price decreased by -4.1% in the last trading session.
Does EARGO INC pay dividends?
EAR does not pay a dividend.
What is the ChartMill rating of EARGO INC stock?
EAR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting EAR stock to perform?
8 analysts have analysed EAR and the average price target is 2.04 USD. This implies a price decrease of -20.62% is expected in the next year compared to the current price of 2.57.
Is EARGO INC (EAR) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EAR.